UnitedHealth Group (NYSE:UNH) Stock Price Up 3.4% After Analyst Upgrade

Key Points

• UNH shares rose 3.4% intraday after JPMorgan raised its price target from $389 to $420 and moved to an overweight rating, with volume about 5% above average.
• Q1 beat and analyst momentum: UnitedHealth topped Q1 EPS estimates ($7.23 vs. $6.76), set FY2026 guidance (~18.25 EPS) and saw multiple price-target raises, leaving a MarketBeat consensus of "Moderate Buy" and an average target around $378.88.
• Insider selling noted: CEO Patrick Conway sold 800 shares at roughly $355 each, a modest reduction in insider ownership that could be perceived negatively by some traders.

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) shares rose 3.4% during mid-day trading on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $389.00 to $420.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. UnitedHealth Group traded as high as $369.63 and last traded at $366.6740. Approximately 10,128,563 shares changed hands during trading, an increase of 5% from the average daily volume of 9,672,083 shares. The stock had previously closed at $354.69.

Several other equities analysts also recently issued reports on UNH. Truist Financial reissued a "buy" rating and set a $395.00 price objective (up from $370.00) on shares of UnitedHealth Group in a research note on Wednesday, April 22nd. Oppenheimer upped their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an "outperform" rating in a research note on Wednesday, April 22nd. Mizuho reduced their price objective on shares of UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating on the stock in a research note on Thursday, February 5th. Barclays upped their price objective on shares of UnitedHealth Group from $327.00 to $373.00 and gave the company an "overweight" rating in a research note on Wednesday, April 22nd. Finally, Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $405.00 to $411.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $378.88.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 800 shares of the company's stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company's stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.28% of the company's stock.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: JPMorgan raised its price target significantly and moved to an overweight rating, giving a clear buy-side signal and lifting sentiment toward a higher valuation. Benzinga: JPMorgan target raise
• Positive Sentiment: Q1 results topped estimates and management set FY2026 guidance in line with stronger margins and Medicare Advantage tailwinds — a fundamentals-driven reason for buying interest. UNH Q1 beats (Yahoo)
• Positive Sentiment: Multiple sell‑side upgrades and target raises (Goldman, RBC, Erste, Argus, Evercore mentions) are pushing consensus targets higher and supporting momentum flows into the shares. Goldman Sachs lift (Zacks)
• Positive Sentiment: Sector and media tailwinds: a new survey on digital mental‑health tools and high‑profile positive mentions (e.g., Jim Cramer) have boosted retail/sector attention. Why Is UnitedHealth Group Surging? (Benzinga)
• Neutral Sentiment: Analyst opinion dispersion — while many targets were raised, some firms remain cautious; that variance increases short‑term trading volatility even as the consensus price target moves up. QuiverQuant: analyst opinions
• Neutral Sentiment: Broader sector earnings (Centene, UHS) and ETF flows (IHF) are influencing healthcare peer comparisons — can lift or temper UNH depending on how investor rotation evolves. Centene Q1 beat (Zacks)
• Negative Sentiment: Insider selling — CEO Patrick Conway sold 800 shares at ~ $355 (filed on Form 4). The amount is modest but can be perceived negatively by some traders. SEC Form 4 (CEO sale)
• Negative Sentiment: Some sell‑side caution and downgrades (including a Seeking Alpha critique and prior Weiss Ratings cut) highlight valuation and regulatory risk concerns — these notes can cap upside for momentum traders. Seeking Alpha downgrade

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Beacon Financial Strategies CORP bought a new position in UnitedHealth Group during the 4th quarter valued at $26,000. Anfield Capital Management LLC lifted its position in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $27,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

The stock's 50-day moving average price is $294.63 and its 200-day moving average price is $316.54. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $333.02 billion, a P/E ratio of 27.69, a P/E/G ratio of 1.53 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same period last year, the firm posted $7.20 EPS. The company's revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group's dividend payout ratio (DPR) is 66.77%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.